CJ-12255 | CAS# 146725-78-2 | Neurokinin-1 Receptor Antagonist

MedKoo Cat#: 412981 | Name: CJ-12255

Description:

WARNING: This product is for research use only, not for human or veterinary use.

CJ-12255 is a Neurokinin-1 Receptor Antagonist.

Chemical Structure

CJ-12255

CAS#146725-78-2

Theoretical Analysis

MedKoo Cat#: 412981

Name: CJ-12255

CAS#: 146725-78-2

Chemical Formula: C32H38N2O3

Exact Mass: 498.2882

Molecular Weight: 498.67

Elemental Analysis: C, 77.08; H, 7.68; N, 5.62; O, 9.63

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

CJ-12255; CJ12255; CJ 12255

IUPAC/Chemical Name

(1R,3R,4S,5S,6S)-6-(Diphenylmethyl)-5-(((2-methoxy-5-(1-methylethyl)phenyl)methyl)amino)-1-azabicyclo(2.2.2)octane-3-carboxylic acid

InChi Key

UGYNIDYASJFWTR-FXZOGHEHSA-N

InChi Code

InChI=1S/C32H38N2O3/c1-21(2)24-14-15-28(37-3)25(18-24)19-33-30-26-16-17-34(20-27(26)32(35)36)31(30)29(22-10-6-4-7-11-22)23-12-8-5-9-13-23/h4-15,18,21,26-27,29-31,33H,16-17,19-20H2,1-3H3,(H,35,36)/t26-,27-,30-,31-/m0/s1

SMILES Code

O=C([C@H]1C[N@@]2[C@@H](C(C3=CC=CC=C3)C4=CC=CC=C4)[C@@H](NCC5=CC(C(C)C)=CC=C5OC)[C@@]1([H])CC2)O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 498.67 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Koon HW, Shih D, Karagiannides I, Zhao D, Fazelbhoy Z, Hing T, Xu H, Lu B, Gerard N, Pothoulakis C. Substance P modulates colitis-associated fibrosis. Am J Pathol. 2010 Nov;177(5):2300-9. doi: 10.2353/ajpath.2010.100314. Epub 2010 Oct 1. PMID: 20889569; PMCID: PMC2966789. 2: Koon HW, Zhao D, Xu H, Bowe C, Moss A, Moyer MP, Pothoulakis C. Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis. Am J Pathol. 2008 Aug;173(2):400-10. doi: 10.2353/ajpath.2008.080222. Epub 2008 Jul 3. PMID: 18599605; PMCID: PMC2475777. 3: Koon HW, Shih DQ, Hing TC, Chen J, Ho S, Zhao D, Targan SR, Pothoulakis C. Substance P induces CCN1 expression via histone deacetylase activity in human colonic epithelial cells. Am J Pathol. 2011 Nov;179(5):2315-26. doi: 10.1016/j.ajpath.2011.07.038. Epub 2011 Sep 23. PMID: 21945803; PMCID: PMC3204086. 4: Karagiannides I, Torres D, Tseng YH, Bowe C, Carvalho E, Espinoza D, Pothoulakis C, Kokkotou E. Substance P as a novel anti-obesity target. Gastroenterology. 2008 Mar;134(3):747-55. doi: 10.1053/j.gastro.2007.12.032. PMID: 18325388; PMCID: PMC2359157. 5: Cassidy MR, Sheldon HK, Gainsbury ML, Gillespie E, Kosaka H, Heydrick S, Stucchi AF. The neurokinin 1 receptor regulates peritoneal fibrinolytic activity and postoperative adhesion formation. J Surg Res. 2014 Sep;191(1):12-8. doi: 10.1016/j.jss.2014.04.030. Epub 2014 Apr 21. PMID: 24836694. 6: Mella JR, Chiswick E, Stepien D, Moitra R, Duffy ER, Stucchi A, Remick D. Antagonism of the Neurokinin-1 Receptor Improves Survival in a Mouse Model of Sepsis by Decreasing Inflammation and Increasing Early Cardiovascular Function. Crit Care Med. 2017 Feb;45(2):e213-e221. doi: 10.1097/CCM.0000000000002075. PMID: 27632670; PMCID: PMC5243197. 7: Reed KL, Stucchi AF, Leeman SE, Becker JM. Inhibitory effects of a neurokinin-1 receptor antagonist on postoperative peritoneal adhesion formation. Ann N Y Acad Sci. 2008 Nov;1144:116-26. doi: 10.1196/annals.1418.010. PMID: 19076371. 8: Reed KL, Heydrick SJ, Aarons CB, Prushik S, Gower AC, Stucchi AF, Becker JM. A neurokinin-1 receptor antagonist that reduces intra-abdominal adhesion formation decreases oxidative stress in the peritoneum. Am J Physiol Gastrointest Liver Physiol. 2007 Sep;293(3):G544-51. doi: 10.1152/ajpgi.00226.2007. Epub 2007 Jul 12. PMID: 17627972. 9: Cohen PA, Gower AC, Stucchi AF, Leeman SE, Becker JM, Reed KL. A neurokinin-1 receptor antagonist that reduces intraabdominal adhesion formation increases peritoneal matrix metalloproteinase activity. Wound Repair Regen. 2007 Nov- Dec;15(6):800-8. doi: 10.1111/j.1524-475X.2007.00291.x. PMID: 18028127. 10: Reed KL, Fruin AB, Gower AC, Stucchi AF, Leeman SE, Becker JM. A neurokinin 1 receptor antagonist decreases postoperative peritoneal adhesion formation and increases peritoneal fibrinolytic activity. Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9115-20. doi: 10.1073/pnas.0403210101. Epub 2004 Jun 8. PMID: 15187234; PMCID: PMC428482.